Amgen Inc (NASDAQ: AMGN)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 09/10/2021
Closing price: 213.75
| Support price level: | N/A |
| Resistance price level: | $231.13 |
| Relative strength index (14-day RSI) | 32.6 |
| Beta | 0.40 |
- AMGN is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
- With a -11.2 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- Down 5.4 percent, AMGN is one of this week's biggest decliners.
- The price of this low-beta stock is expected to increase by 0.40% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- Price broke below prior support level - a short-term bearish signal.
| Low | High | Price as % of Range |
| $213.75 | $259.14 | 0.0% |
| 200 day | 50 day | 20 day | 10 day |
| $238.28 | $234.35 | $223.97 | $221.97 |
| Historical (5 year) |
Last month | Current estimate | Next month forecast |
| 25.4% | 30.7% | 26.7% | 25.4% |
- 7.3% in the next week.
- 14.4% in the next month.
- 61.5% in the next year.
